CN105918717A - 一种功能性营养素饮料 - Google Patents
一种功能性营养素饮料 Download PDFInfo
- Publication number
- CN105918717A CN105918717A CN201610266517.4A CN201610266517A CN105918717A CN 105918717 A CN105918717 A CN 105918717A CN 201610266517 A CN201610266517 A CN 201610266517A CN 105918717 A CN105918717 A CN 105918717A
- Authority
- CN
- China
- Prior art keywords
- beverage
- functional nutrient
- vitamin
- functional
- nutrient beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 47
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract description 28
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 8
- 150000004676 glycans Chemical class 0.000 abstract description 8
- 229920001282 polysaccharide Polymers 0.000 abstract description 8
- 239000005017 polysaccharide Substances 0.000 abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 abstract description 6
- 241000167854 Bourreria succulenta Species 0.000 abstract description 6
- 235000014837 Malpighia glabra Nutrition 0.000 abstract description 6
- 235000019693 cherries Nutrition 0.000 abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 6
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 5
- 229960003080 taurine Drugs 0.000 abstract description 4
- 208000027219 Deficiency disease Diseases 0.000 abstract description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 3
- 229930003779 Vitamin B12 Natural products 0.000 abstract description 3
- 229930003537 Vitamin B3 Natural products 0.000 abstract description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract description 3
- 229960003512 nicotinic acid Drugs 0.000 abstract description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019163 vitamin B12 Nutrition 0.000 abstract description 3
- 239000011715 vitamin B12 Substances 0.000 abstract description 3
- 235000019160 vitamin B3 Nutrition 0.000 abstract description 3
- 239000011708 vitamin B3 Substances 0.000 abstract description 3
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 3
- 239000011726 vitamin B6 Substances 0.000 abstract description 3
- 229940011671 vitamin b6 Drugs 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 230000006698 induction Effects 0.000 abstract description 2
- 241000233866 Fungi Species 0.000 abstract 2
- 241001640002 Malpighia emarginata Species 0.000 abstract 2
- 230000032683 aging Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 241001506047 Tremella Species 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 240000003394 Malpighia glabra Species 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000004958 brain cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241001300479 Macroptilium Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 244000002791 Myrciaria paraensis Species 0.000 description 1
- 235000016392 Myrciaria paraensis Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
- 229960000516 bezafibrate Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- KFZAUHNPPZCSCR-UHFFFAOYSA-N iron zinc Chemical compound [Fe].[Zn] KFZAUHNPPZCSCR-UHFFFAOYSA-N 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种功能性营养素饮料，其特征在于，每1kg饮料中含有：针叶樱桃果粉50‑250mg、银耳多糖25‑200mg、VB3 5‑20mg、VB6 0.5‑2mg、VB12 0.0005‑0.005mg、牛磺酸200‑600mg、γ‑氨基丁酸50‑250mg。本发明将γ‑氨基丁酸与针叶樱桃果粉、银耳多糖、牛磺酸、维生素B3、维生素B6和维生素B12配伍协同作用，制备得到一种功能性营养素饮料，该饮料具有提高免疫力、抗衰老、降血糖和降血脂等多种生理功能；并同时具有全面补充多种营养，增强营养功能，调理人体机能健康和缺乏某种营养素引起的潜在的缺乏症，有效防止趋于亚健康状态，引起免疫力下降和诱发疾病等。
Description
技术领域
本发明属于营养素饮料领域，具体地，本发明涉及一种功能性营养素饮料。
背景技术
针叶樱桃是目前种植的植物中维生素C含量第三高的，每100克果中维C含量达1677毫克，仅次于卡卡杜李和卡姆果，是柠檬的31倍，草莓的27倍，猕猴桃的18倍，也是被认为维生素C极高的番石榴的7倍，是名副其实的“天然维生素C之王”之一，同时还含有维A、维B1、维B2、铁、钙等元素，维生素C是维持人体生命不可欠缺的重要成份，它能够防感冒，防坏血病，改善人体抵抗能力，对美容以及癌症有一定功效。在保健、饮料、美容方面有广泛的应用。
从银耳(Tremella fuciformisBerk)，俗称白木耳，子实体中得到银耳多糖(Tremellam)是一种酸性杂多糖，其主链结构是由α-(1→3)糖苷键连接的甘露聚糖，支链由葡萄糖醛酸和木糖组成。
γ-氨基丁酸(GABA)是一种天然活性成分，广泛分布于动植物体内。植物如豆属、参属、中草药等的种子、根茎和组织液中都含有GABA。在动物体内，GABA几乎只存在于神经组织中，其中脑组织中的含量大约为0.1-0.6mg/克组织，免疫学研究表明，其浓度最高的区域为大脑中黑质。
根据目前的研究，发现GABA的生理活性主要表现在以下几方面：
(1)镇静神经、抗焦虑。医学家已经证明GABA是中枢神经系统的抑制性传递物质，是脑组织中最重要的神经递质之一。其作用是降低神经元活性，防止神经细胞过热，GABA能结合抗焦虑的脑受体并使之激活，然后与另外一些物质协同作用，阻止与焦虑相关的信息抵达脑指示中枢。
(2)降低血压。GABA能作用于脊髓的血管运动中枢，有效促进血管扩张，达到降低血压的目的。据报道，黄芪等中药的有效降压成分即为GABA。
(3)治疗疾病。1997年，大熊诚太郎的研究表明GABA与某些疾病的形成有关，帕金森病人脊髓中GABA的浓度较低，癫痫病患者脊髓液中的GABA浓度也低于正常水平。日本大阪大学医学院的研究显示GABA对Kupperman综合症具有显著的改善效果。另外，神经组织中GABA的降低也与Huntington疾病、老年痴呆等神经衰败症的形成有关。
(4)降低血氨。我国的临床医学和日本的研究者也都认为，GABA能抑制谷氨酸的脱羧反应，使血氨降低。更多的谷氨酸与氨结合生成尿素排出体外，以解除氨毒，从而增进肝机能。摄入GABA可以提高葡萄糖磷酸酯酶的活性，使脑细胞活动旺盛，可促进脑组织的新陈代谢和恢复脑细胞功能，改善神经机能。
(5)提高脑活力。GABA能进入脑内三羧酸循环，促进脑细胞代谢，同时还能提高葡萄糖代谢时葡萄糖磷酸酯酶的活性，增加乙酰胆碱的生成，扩张血管增加血流量，并降低血氨，促进大脑的新陈代谢，恢复脑细胞功能。
(6)促进乙醇代谢。以嗜酒者为对象，服用GABA再饮用60ml威士忌后采血测定血中乙醇及乙醛浓度，发现后者浓度明显比对照组低。
(7)其他。最新的研究表明，GABA还具有防止皮肤老化、消除体臭、改善脂质代谢，防止动脉硬化高效减肥等功能。
发明内容
本发明所要解决的技术问题是提供一种功能性营养素饮料及其制备方法。本发明将γ-氨基丁酸与针叶樱桃果粉、银耳多糖、牛磺酸、维生素B3、维生素B6和维生素B12配伍协同作用，制备得到一种功能性营养素饮料，该饮料具有提高免疫力、抗衰老、降血糖和降血脂等多种生理功能；并同时具有全面补充多种营养，增强营养功能，调理人体机能健康和缺乏某种营养素引起的潜在的缺乏症，有效防止趋于亚健康状态，引起免疫力下降和诱发疾病等。
本发明解决上述技术问题所采用的技术方案是：
一种功能性营养素饮料，制备成水基饮料时，每1kg饮料中含有：
进一步的技术方案中，所述的一种功能性营养素饮料，制备成水基饮料时，每1kg饮料中含有：
进一步的技术方案中，所述的一种功能性营养素饮料，制备成水基饮料时，每1kg饮料中含有：
进一步的技术方案中，所述的一种功能性营养素饮料，还包括适于在饮料中添加的饮料食品添加剂。
所述饮料食品添加剂包括甜味调节剂、酸度调节剂、着色剂、食用香精。
所述甜味调节剂选自白砂糖、葡萄糖、和浓缩白葡萄汁的一种或多种。
所述酸度调节剂包括柠檬酸、柠檬酸钠。
所述着色剂包括柠檬黄、亮蓝等适合于在饮料中添加的着色剂。
所述食用香精包括清凉香精、混合水果香精、食用香精。
所述饮料食品添加剂还包括例如锌铁钙强化的营养添加剂，例如在所述饮料中添加L-乳酸钙、葡萄糖酸亚铁、葡萄糖酸锌中的一种或多种。
本发明还提供了一种营养素组合物，包括以下按重量分数计的成分：
进一步的技术方案中，所述的一种营养素组合物，包括以下按重量分数计的成分：
进一步的技术方案中，所述的营养素组合物，包括以下按重量分数计的成分：
本发明中，所述针叶樱桃果粉是以针叶樱桃果为原料，经榨汁、过滤、浓缩、喷雾干燥等工艺制成。
本发明中，所述银耳多糖是以银耳为原料，经过纯水洗涤、浸泡、加热提取、过滤除杂、乙醇沉淀、乙醇脱水、干燥、粉碎、过筛、包装等工艺制成。本发明中使用的银耳多糖原料要求：总多糖(以干物质计算)大于等于50％，按照苯酚硫酸法测定。
本发明与现有技术相比，具有如下优点：
本发明将γ-氨基丁酸与针叶樱桃果粉、银耳多糖、牛磺酸、维生素B3、维生素B6和维生素B12配伍协同作用，制备得到一种功能性营养素饮料，该饮料具有提高免疫力、抗衰老、降血糖和降血脂等多种生理功能；并同时具有全面补充多种营养，增强营养功能，调理人体机能健康和缺乏某种营养素引起的潜在的缺乏症，有效防止趋于亚健康状态，引起免疫力下降和诱发疾病等。
具体实施方式
为了更好地理解本发明的内容，下面结合具体实施例作进一步说明。
应理解，这些实施例仅用于对本发明进一步说明，而不用于限制本发明的范围。此外应理解，在阅读了本发明所述的内容后，该领域的技术人员对本发明作出一些非本质的改动或调整，仍属于本发明的保护范围。
实施例1
一种功能性营养素饮料，每1kg饮料中含有：
取30个患者(高血压、高血脂患者)分为2组，实验组20人，对照组10人，实验组使用本发明实施例1的产品进行饮用，用量为每次500ml，每天两次；对照组使用药物“必降脂”，按说明书使用。
患者的选取标准为医学上确认存在三高症：高血压、高血脂、高血清胆固醇。连续使用两个月，每个月一疗程，实验开始和结束时分别检测患者三高指标，所得结果如下(各单位均为医学标准单位，即胆固醇、甘油三酯为mmol/l，血压为mmHg)：
临床结果见下表：
实施例2
一种功能性营养素饮料，每1kg饮料中含有：
实施例3
一种功能性营养素饮料，每1kg饮料中含有：
如上所述，便可以较好地实现本发明。
Claims (7)
1.一种功能性营养素饮料，其特征在于，每1kg饮料中含有：
2.如权利要求1所述的一种功能性营养素饮料，其特征在于，每1kg饮料中含有：
3.如权利要求1所述的一种功能性营养素饮料，其特征在于，每1kg饮料中含有：
4.如权利要求1～3任意一项所述的一种功能性营养素饮料，其特征在于，还包括适于在饮料中添加的饮料添加剂。
5.一种营养素组合物，其特征在于，包括以下按重量分数计的成分：
6.如权利要求4所述的一种营养素组合物，其特征在于，包括以下按重量分数计的成分：
7.如权利要求4所述的营养素组合物，其特征在于，包括以下按重量分数计的成分：
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610266517.4A CN105918717A (zh) | 2016-04-26 | 2016-04-26 | 一种功能性营养素饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610266517.4A CN105918717A (zh) | 2016-04-26 | 2016-04-26 | 一种功能性营养素饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105918717A true CN105918717A (zh) | 2016-09-07 |
Family
ID=56837437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610266517.4A Pending CN105918717A (zh) | 2016-04-26 | 2016-04-26 | 一种功能性营养素饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105918717A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105942533A (zh) * | 2016-06-29 | 2016-09-21 | 成都博创必成医药技术有限公司 | 一种功能性饮料及功能性饮料泡腾片 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069866A (zh) * | 1992-06-24 | 1993-03-17 | 渝州大学 | 银耳多糖饮料及其制备方法 |
| KR100349201B1 (ko) * | 1999-12-02 | 2003-03-31 | 주식회사 비락 | 연근음료 및 그 제조방법 |
| CN104382004A (zh) * | 2013-08-19 | 2015-03-04 | 宣城柏维力生物工程有限公司 | 一种针叶樱桃vc泡腾片 |
| CN104509919A (zh) * | 2013-09-30 | 2015-04-15 | 张自力 | 一种功能性营养素饮料 |
| CN105249128A (zh) * | 2015-11-06 | 2016-01-20 | 上海立足生物科技有限公司 | 一种维生素b族固体饮料 |
-
2016
- 2016-04-26 CN CN201610266517.4A patent/CN105918717A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069866A (zh) * | 1992-06-24 | 1993-03-17 | 渝州大学 | 银耳多糖饮料及其制备方法 |
| KR100349201B1 (ko) * | 1999-12-02 | 2003-03-31 | 주식회사 비락 | 연근음료 및 그 제조방법 |
| CN104382004A (zh) * | 2013-08-19 | 2015-03-04 | 宣城柏维力生物工程有限公司 | 一种针叶樱桃vc泡腾片 |
| CN104509919A (zh) * | 2013-09-30 | 2015-04-15 | 张自力 | 一种功能性营养素饮料 |
| CN105249128A (zh) * | 2015-11-06 | 2016-01-20 | 上海立足生物科技有限公司 | 一种维生素b族固体饮料 |
Non-Patent Citations (3)
| Title |
|---|
| 冯悟庸 等: "《南方丘陵山区农机化适用技术》", 31 March 1994, 贵州教育出版社 * |
| 唐玉海 主编: "《有机化学》", 31 July 2011, 化学工业出版社 * |
| 崔立勋: "《生物药物分离与纯化技术》", 31 January 2015, 中国质检出版社 中国标准出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105942533A (zh) * | 2016-06-29 | 2016-09-21 | 成都博创必成医药技术有限公司 | 一种功能性饮料及功能性饮料泡腾片 |
| CN105942533B (zh) * | 2016-06-29 | 2019-06-11 | 成都博创必成医药技术有限公司 | 一种功能性饮料及功能性饮料泡腾片 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178314B (zh) | 一种辅助降血压功能的苦荞保健饮料及其生产工艺 | |
| CN102742656B (zh) | 一种缓解视力疲劳的奶茶及其制备方法 | |
| CN101773595B (zh) | 清肝明目中药茶 | |
| CN103054113A (zh) | 一种具有降血糖功效的复合果蔬汁饮料 | |
| CN105112265A (zh) | 一种保健无花果酒及其制作方法 | |
| CN102987477B (zh) | 一种保健饮料 | |
| CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
| CN102845795A (zh) | 一种功能性保健饮料 | |
| CN104187914A (zh) | 一种红石榴果汁饮料及其制备方法 | |
| CN107996927A (zh) | 提高免疫力的组合物、饮料及其制备方法 | |
| CN110897147A (zh) | 铁皮石斛解酒保肝组合物和制法 | |
| CN105878812B (zh) | 以金花茶-石斛为原料的解酒饮料及其生产方法 | |
| CN103238889B (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
| EP2891496B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX EXTRACT OF CRATAEGI FRUCTUS and CITRI PERICARPIUM AS AN ACTIVE INGREDIENT FOR TREATING OR PREVENTING OBESITY OR LIPID-RELATED METABOLIC DISEASES | |
| CN104872775B (zh) | 一种绿茶茶多糖复合型减肥固体饮料和应用 | |
| CN106798214A (zh) | 一种沙棘饮料及其制备方法 | |
| CN106360243A (zh) | 一种具有抗氧化功能的银耳复合固体饮料及其制备方法 | |
| CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
| CN104305414A (zh) | 一种蓝莓汁 | |
| CN107028169A (zh) | 一种改善记忆力的组合物及其制备方法 | |
| CN103829342B (zh) | 功能性保健饮料及其制备方法 | |
| CN105918717A (zh) | 一种功能性营养素饮料 | |
| CN102613648B (zh) | 一种原生态竹锗营养液的制备方法 | |
| CN105087285B (zh) | 一种复方桑葚养生酒及其制备方法 | |
| CN101642256B (zh) | 一种去痘美容牛奶的制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160907 |
|
| RJ01 | Rejection of invention patent application after publication |